CareDx, Inc (CDNA) Ownership
CDNA ownership summary
as of October 18, 2026- Institutions
- 103.8% of shares outstanding
- Insiders
- 3.10% of shares outstanding
- Shares outstanding
- 51.7M
- Float
- 49.5M shares available to trade
- Short interest
- 12.97% 6.6M shares short
- Days to cover
- 5.19 short interest up 4.6% vs prior month
- Institutions 103.79%
- Insiders 3.10%
CDNA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 9.31% | 4.8M | $308.1M | +292,613 (+6.5%) | June 30, 2026 |
| 2 | State Street Corp | 4.77% | 2.5M | $158.0M | −291,527 (−10.6%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 4.25% | 2.2M | $140.6M | +37,018 (+1.7%) | June 30, 2026 |
| 4 | Deerfield Management Co | 3.86% | 2.0M | $127.8M | −193,382 (−8.8%) | June 30, 2026 |
| 5 | ARK Investment Management LLC | 3.78% | 2.0M | $125.0M | −274,025 (−12.3%) | June 30, 2026 |
| 6 | Boston Partners Global Investors, Inc | 3.75% | 1.9M | $124.0M | +54,067 (+2.9%) | June 30, 2026 |
| 7 | BAMCO Inc | 3.74% | 1.9M | $124.0M | −1.4M (−41.9%) | June 30, 2026 |
| 8 | Gagnon Securities LLC | 3.42% | 1.8M | $113.3M | +8,861 (+0.5%) | June 30, 2026 |
| 9 | Chevy Chase Trust Holdings, Inc. | 2.78% | 1.4M | $92.0M | −66,659 (−4.4%) | June 30, 2026 |
| 10 | Geode Capital Management, LLC | 2.57% | 1.3M | $85.0M | +73,923 (+5.9%) | June 30, 2026 |
| 11 | Ophir Asset Management Pty Ltd | 2.44% | 1.3M | $80.9M | +276,758 (+28.0%) | June 30, 2026 |
| 12 | Renaissance Technologies Corp | 2.40% | 1.2M | $79.5M | +58,561 (+4.9%) | June 30, 2026 |
| 13 | BRAIDWELL LP | 2.36% | 1.2M | $78.1M | −952,544 (−43.8%) | June 30, 2026 |
| 14 | Arnhold & S. Bleichroeder Advisers, LLC | 2.31% | 1.2M | $76.6M | +621,629 (+108.0%) | June 30, 2026 |
| 15 | Sumitomo Mitsui Trust Group Inc | 2.30% | 1.2M | $76.3M | −283,496 (−19.2%) | June 30, 2026 |
| 16 | Blue Water Life Science Advisors, LLC | 2.30% | 1.2M | $76.2M | +255,000 (+27.3%) | June 30, 2026 |
| 17 | Amova Asset Management Americas, Inc | 2.30% | 1.2M | $76.0M | −287,051 (−19.5%) | June 30, 2026 |
| 18 | Dimensional Fund Advisors, Inc. | 2.28% | 1.2M | $75.6M | −280,837 (−19.2%) | June 30, 2026 |
| 19 | D. E. Shaw & Co LP | 2.20% | 1.1M | $72.8M | +262,752 (+30.0%) | June 30, 2026 |
| 20 | Jacobs Levy Equity Management, Inc. | 1.92% | 996K | $63.7M | +131,201 (+15.2%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 2.1M shares and 9 cut 4.0M.
CDNA top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.01% | 1.6M | $99.6M | −2,181 (−0.1%) | August 31, 2026 |
| 2 | ARK Genomic Revolution ETF | 2.87% | 1.5M | $94.9M | +3,626 (+0.2%) | September 30, 2026 |
| 3 | State Street® SPDR® S&P® Biotech ETF | 2.57% | 1.3M | $85.1M | −25,400 (−1.9%) | September 30, 2026 |
| 4 | iShares Russell 2000 ETF | 2.57% | 1.3M | $85.1M | −15,296 (−1.1%) | September 30, 2026 |
| 5 | Baron Discovery Institutional | 1.99% | 1.0M | $65.7M | −346,577 (−25.2%) | September 30, 2026 |
| 6 | Fidelity Small Cap Index | 1.08% | 561K | $35.9M | +4,939 (+0.9%) | July 31, 2026 |
| 7 | Amova ARK Pstv Chg Innovt P JPY Acc | 1.01% | 524K | $33.6M | −227,909 (−30.3%) | August 31, 2026 |
| 8 | iShares Russell 2000 Growth ETF | 0.93% | 480K | $30.7M | −607 (−0.1%) | September 30, 2026 |
| 9 | Strategic Advisers U.S. Total Stock | 0.90% | 464K | $29.7M | −124,984 (−21.2%) | August 31, 2026 |
| 10 | First Eagle Small Cap Opportunity I | 0.77% | 400K | $25.6M | −56,983 (−12.5%) | September 30, 2026 |
| 11 | iShares Biotechnology ETF | 0.71% | 369K | $23.6M | −2,800 (−0.8%) | September 30, 2026 |
| 12 | Vanguard Russell 2000 ETF | 0.58% | 298K | $19.1M | +3,273 (+1.1%) | September 30, 2026 |
| 13 | JNL Multi-Manager Small Cap Growth A | 0.56% | 289K | $18.5M | −181,531 (−38.6%) | June 30, 2026 |
| 14 | Heptagon Driehaus US Micro Cap Eq C$ Acc | 0.55% | 284K | $18.2M | +149,665 (+111.3%) | August 31, 2026 |
| 15 | Schwab US Small-Cap ETF™ | 0.53% | 272K | $17.4M | +180 (+0.1%) | September 30, 2026 |
| 16 | Fidelity Extended Market Index | 0.48% | 250K | $16.0M | −5,508 (−2.2%) | August 31, 2026 |
| 17 | Vanguard Strategic Equity Inv | 0.45% | 235K | $15.0M | +71,585 (+43.8%) | June 30, 2026 |
| 18 | Fidelity Enhanced Small Cap Core ETF | 0.44% | 227K | $14.6M | +474 (+0.2%) | September 30, 2026 |
| 19 | DFA US Small Cap I | 0.44% | 226K | $14.5M | — | August 31, 2026 |
| 20 | WPG Partners Select Small Cap Value Ins | 0.43% | 222K | $14.2M | −36,954 (−14.3%) | July 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CDNA insider transactions
latest 12| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-16 | John Walter Hanna Jr | Sell | $21.12 | 10,282 | $217,156 |
| 2026-01-22 | John Walter Hanna Jr | Sell | $21.16 | 19,280 | $407,965 |
| 2026-01-21 | John Walter Hanna Jr | Sell | $21.00 | 200 | $4,200 |
| 2026-01-15 | John Walter Hanna Jr | Sell | $21.05 | 10,156 | $213,784 |
| 2025-07-07 | Peter Maag | Sell | $18.58 | 10,000 | $185,800 |
| 2025-06-18 | Hannah Valantine | Sell | $19.16 | 10,570 | $202,521 |
| 2025-06-17 | Peter Maag | Sell | $19.24 | 10,000 | $192,400 |
| 2025-06-11 | William A Hagstrom | Sell | $19.90 | 19,391 | $385,881 |
| 2025-05-28 | William A Hagstrom | Sell | $17.45 | 30,000 | $523,500 |
| 2025-05-12 | Christine Cournoyer | Sell | $15.96 | 29,136 | $465,011 |
| 2025-05-06 | Christine Cournoyer | Sell | $14.13 | 16,700 | $235,971 |
| 2025-04-30 | Peter Maag | Sell | $17.23 | 13,281 | $228,832 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CDNA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CDNA
Institutional investors own 103.8% of CareDx's shares and insiders 3.10%. The largest holder is BlackRock Inc with 9.31% of the shares (4.8M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 9 reduced their stake in the latest filings. Short interest is 12.97% of the float, or 5.19 days of average trading volume. The share count rose 321.5% since 2014.
Related: CDNA analyst forecast, CDNA key metrics. See the CDNA stock overview for the latest quote and news.
CDNA ownership FAQ
Who owns the most CareDx stock?
The largest shareholders of CareDx are BlackRock Inc (9.31%), State Street Corp (4.77%), Vanguard Capital Management, LLC (4.25%), Deerfield Management Co (3.86%), ARK Investment Management LLC (3.78%).
What percentage of CareDx is owned by institutions?
Institutions hold 103.8% of CareDx's shares outstanding; insiders hold 3.10%.
Which funds own CareDx?
The largest fund holders of CareDx are Vanguard MStar Total Stk Mkt Idx Invest (3.01%), ARK Genomic Revolution ETF (2.87%), State Street® SPDR® S&P® Biotech ETF (2.57%), iShares Russell 2000 ETF (2.57%), Baron Discovery Institutional (1.99%).
What is CareDx's short interest?
6.6M shares of CareDx were sold short, 12.97% of the float; at the average daily volume it would take 5.19 days to cover.
Are insiders buying or selling CareDx?
Of the latest 12 reported insider transactions in CareDx (since April 30, 2025), 0 were purchases and 12 were sales.
How many shares of CareDx are outstanding?
CareDx has 51.7M shares outstanding, of which 49.5M are in the public float.